Evaluated articles

A list by Rapid Reviews Infectious Diseases

Articles that have been evaluated by Rapid Reviews COVID-19.

This list contains 549 articles Last updated Dec 1, 2025

This list can be subscribed to via the RSS
Find related articles using our Article recommendations
This list on Sciety

Showing page 21 of 55 pages of list content

Release of P-TEFb from the Super Elongation Complex promotes HIV-1 latency reversal

This article's authors
1. William J. Cisneros
2. Miriam Walter
3. Shimaa H.A. Soliman
4. Lacy M. Simons
5. Daphne Cornish
6. Ariel W. Halle
7. Eun-Young Kim
8. Steven M. Wolinsky
9. Ali Shilatifard
10. Judd F. Hultquist
This article has 4 evaluations Latest evaluation on Apr 9, 2024 Published on Mar 2, 2024 Added on Apr 10, 2024
Pneumocystis murina Promotes Inflammasome Formation and NETosis during Pneumocystis Pneumonia

This article's authors
1. Steven G. Sayson
2. Alan Ashbaugh
3. Aleksey Porollo
4. Melanie T. Cushion
This article has 4 evaluations Latest evaluation on Mar 30, 2024 Published on Feb 18, 2024 Added on Mar 31, 2024
Prevalent and persistent new-onset autoantibodies in mild to severe COVID-19

This article's authors
1. August Jernbom Falk
2. Lovisa Skoglund
3. Elisa Pin
4. Ronald Sjöberg
5. Hanna Tegel
6. Sophia Hober
7. Elham Rostami
8. Annica Rasmusson
9. Janet L. Cunningham
10. Sebastian Havervall
11. Charlotte Thålin
12. Anna Månberg
13. Peter Nilsson
This article has 5 evaluations Latest evaluation on Mar 28, 2024 Published on Apr 30, 2024 Added on Mar 29, 2024
Evaluation of four interventions using behavioural economics insights to increase demand for voluntary medical male circumcision in South Africa through the MoyaApp: A quasi-experimental study

This article's authors
1. Preethi Mistri
2. Silviu Tomescu
3. Simamkele Bokolo
4. Alexandra De Nooy
5. Pedro T. Pisa
6. Skye Grove
7. Laura Schmucker
8. Candice Chetty-Makkan
9. Lawrence Long
10. Alison Buttenheim
11. Brendan Maughan-Brown
This article has 4 evaluations Latest evaluation on Mar 28, 2024 Published on Jan 20, 2024 Added on Mar 29, 2024
Semi-synthetic glycoconjugate vaccine candidate against Cryptococcus neoformans

This article's authors
1. Conor J. Crawford
2. Livia Liporagi-Lopes
3. Carolina Coelho
4. Samuel R. Santos Junior
5. André Moraes Nicola
6. Maggie P. Wear
7. Raghav Vij
8. Stefan Oscarson
9. Arturo Casadevall
This article has 5 evaluations Latest evaluation on Mar 25, 2024 Published on Feb 3, 2024 Added on Mar 26, 2024
Estimating the reproduction number and transmission heterogeneity from the size distribution of clusters of identical pathogen sequences

This article's authors
1. Cécile Tran-Kiem
2. Trevor Bedford
This article has 7 evaluations Latest evaluation on Mar 20, 2024 Published on Feb 8, 2024 Added on Mar 14, 2024
Yellow fever in Ghana: Predicting emergence and ecology from historical outbreaks

This article's authors
1. Seth D. Judson
2. Ernest Kenu
3. Trevon Fuller
4. Franklin Asiedu-Bekoe
5. Alberta Biritwum-Nyarko
6. Lee F. Schroeder
7. David W. Dowdy
This article has 8 evaluations Latest evaluation on Mar 23, 2024 Published on Jan 30, 2024 Added on Mar 13, 2024
Blood transcriptomics reveal persistent SARS-CoV-2 RNA and candidate biomarkers in Long COVID patients

This article's authors
1. Soraya Maria Menezes
2. Marc Jamoulle
3. Maria Paula Carletto
4. Leen Moens
5. Isabelle Meyts
6. Piet Maes
7. Johan Van Weyenbergh
This article has 4 evaluations Latest evaluation on Mar 12, 2024 Published on Jan 17, 2024 Added on Mar 13, 2024
Evidence of artemisinin partial resistance in North-western Tanzania: clinical and drug resistance markers study

This article's authors
1. Deus S. Ishengoma
2. Celine I. Mandara
3. Catherine Bakari
4. Abebe A. Fola
5. Rashid A. Madebe
6. Misago D. Seth
7. Filbert Francis
8. Creyton Buguzi
9. Ramadhan Moshi
10. Issa Garimo
11. Samwel Lazaro
12. Abdallah Lusasi
13. Sijenunu Aaron
14. Frank Chacky
15. Ally Mohamed
16. Ritha J. A. Njau
17. Jovin Kitau
18. Charlotte Rasmussen
19. Jeffrey A. Bailey
20. Jonathan J. Juliano
21. Marian Warsame
This article has 6 evaluations Latest evaluation on Mar 28, 2024 Published on Feb 1, 2024 Added on Mar 9, 2024
How does treatment coverage and proportion never treated influence the success of Schistosoma mansoni elimination as a public health problem by 2030?

This article's authors
1. Klodeta Kura
2. Nyamai Mutono
3. Maria-Gloria Basáñez
4. Luc E. Coffeng
5. S.M. Thumbi
6. Roy M. Anderson
This article has 4 evaluations Latest evaluation on Mar 5, 2024 Published on Oct 21, 2023 Added on Mar 6, 2024

Previous Next

Evaluated articles

Release of P-TEFb from the Super Elongation Complex promotes HIV-1 latency reversal

Pneumocystis murina Promotes Inflammasome Formation and NETosis during Pneumocystis Pneumonia

Prevalent and persistent new-onset autoantibodies in mild to severe COVID-19

Evaluation of four interventions using behavioural economics insights to increase demand for voluntary medical male circumcision in South Africa through the MoyaApp: A quasi-experimental study

Semi-synthetic glycoconjugate vaccine candidate against Cryptococcus neoformans

Estimating the reproduction number and transmission heterogeneity from the size distribution of clusters of identical pathogen sequences

Yellow fever in Ghana: Predicting emergence and ecology from historical outbreaks

Blood transcriptomics reveal persistent SARS-CoV-2 RNA and candidate biomarkers in Long COVID patients

Evidence of artemisinin partial resistance in North-western Tanzania: clinical and drug resistance markers study

How does treatment coverage and proportion never treated influence the success of Schistosoma mansoni elimination as a public health problem by 2030?